CALGARY, AB and MOUNTAIN Check out, Calif., May perhaps 31, 2022 /PRNewswire/ – Willow Biosciences Inc. (“Willow” or the “Firm“) (TSX: WLLW) (OTCQB: CANSF), a main biotechnology firm centered on revolutionizing industrial production of pure, dependable and sustainable substances  is happy to announce these days that is has been engaged by a specialty pharmaceutical organization (the “Counterparty“) to enhance an enzyme vital to the progress of a substantial volume Energetic Pharmaceutical Ingredient (API) employed in nutraceutical and pharmaceutical products. The Counterparty is partnered with a large-cap, multi-national health care enterprise.

“This is a important stage ahead in the evolution of Willow’s small business”, claimed Trevor Peters, Willow’s President and Main Govt Officer. “This new partnership highlights the abilities of our scientific group, and demonstrates to our stakeholders the extensive array of alternatives accessible to Willow’s complete FutureGrownTM technologies platform. As Willow carries on to broaden its capabilities and include new partnerships, Willow is on a path to getting to be the premier identify in biobased manufacturing.”

The job consists of research & development and commercialization phases, with earnings coming from each analysis service fees and milestone payments. Following commercialization, Willow anticipates an on-likely income stream from license payments.

About Willow Biosciences Inc.

Willow develops and creates high-purity elements for the particular care, foods and beverage, and pharmaceutical marketplaces. Willow’s FutureGrownTM biotechnology system permits large-scale production with sustainability at its main. Willow’s R&D workforce has a verified track document of establishing and commercializing bio-dependent manufacturing processes and products to advantage our B2B companions and their customers.

For additional information, you should take a look at our site at www.willowbio.com

Forward-Seeking Statements

This information launch may possibly include things like ahead-looking statements such as viewpoints, assumptions, estimates and the Firm’s assessment of upcoming strategies and operations, and, far more especially, statements relating to: the capability to accommodate new plans and to develop abilities, such as in regard of a new partnered pharmaceutical project the demand from customers and marketplace measurement opportunity of the artificial cannabinoid business and the enterprise prepare of the Corporation, generally, such as getting to be a chief in precision fermentation, cannabinoid research and generation. When applied in this news launch, the text “will,” “foresee,” “imagine,” “estimate,” “assume,” “intent,” “may perhaps,” “job,” “really should,” and identical expressions are meant to be amid the statements that detect ahead-looking statements. The ahead-wanting statements are established on the basis of anticipations and assumptions manufactured by the Organization which consist of, but are not limited to: the accomplishment of Willow’s strategic partnerships, such as the growth of potential strategic partnerships the fiscal strength of the Firm the ability of the Enterprise to fund its small business plan applying hard cash on hand and current resources the current market for Willow’s products the capacity of the Company to acquire and retain applicable licences the capacity of the Firm to acquire suited production associates and other strategic interactions and the prosperous implementation of Willow’s commercialization and creation tactic, frequently. Forward-hunting statements are matter to a wide vary of dangers and uncertainties, and even though the Business believes that the expectations represented by such ahead-hunting statements are acceptable, there can be no assurance that this kind of anticipations will be recognized. Any range of critical things could result in precise success to vary materially from people in the ahead-looking statements which include, but not confined to, hazards involved with: the cannabinoid market in common the achievement of the Company’s study and improvement strategies infringement on mental residence failure to advantage from partnerships or correctly integrate acquisitions actions and initiatives of federal and provincial governments and alterations to government guidelines and the execution and affect of these actions, initiatives and procedures import/export and study restrictions for cannabinoid-primarily based operations the dimension of the health care-use and adult-use cannabinoid current market competition from other marketplace contributors adverse U.S., Canadian and worldwide financial situations adverse world events and general public-health and fitness crises, such as the existing COVID-19 outbreak failure to comply with specified rules departure of important management personnel or lack of ability to entice and keep expertise and other elements more completely described from time to time in the reviews and filings built by the Business with securities regulatory authorities. Remember to refer to the Firm’s most latest annual details variety and management’s discussion and analysis for further chance things relating to Willow, which can be accessed possibly on Willow’s web-site at www.willowbio.com or underneath the Firm’s profile on www.sedar.com.

Any financial outlook and upcoming-oriented economical facts contained in this document relating to potential economic general performance, monetary position, hard cash balances or income is centered on assumptions about future functions, which include economic ailments and proposed courses of motion dependent on management’s assessment of the suitable details that is now available. Projected operational information and facts consists of forward-wanting facts and is based mostly on a selection of product assumptions and components, as are set out earlier mentioned. These projections may possibly also be considered to incorporate upcoming-oriented economic facts or a money outlook. The precise benefits of the Firm’s functions for any time period will most likely range from the amounts established forth in these projections and this sort of variants might be product. Real benefits will change from projected effects. Audience are cautioned that any these kinds of financial outlook and long run-oriented economical facts contained herein should really not be utilized for uses other than all those for which it is disclosed herein.

The ahead-seeking statements contained in this news release are created as of the date hereof and the Enterprise does not undertake any obligation to update publicly or to revise any of the integrated forward-hunting statements, besides as necessary by applicable legislation. The forward-on the lookout statements contained herein are expressly qualified by this cautionary assertion.



View unique articles to down load multimedia:https://www.prnewswire.com/information-releases/willow-biosciences-expands-its-portfolio-with-a-new-partnered-pharmaceutical-project-301557628.html

Resource Willow Biosciences Inc.